Alex Thompson Score: 32
Analyst at
Stifel Nicolaus
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+62.3%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
70%
21 W / 9 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
47%
8 W / 9 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
6%
1 W / 16 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
6%
1 W / 16 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
67%
18 W / 9 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
70%
21 W / 9 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 |
Crinetics Pharmaceuticals Inc
CRNX
|
BUY |
$83.00
Est. +130%
|
$36.06 | $42.41 |
Pending
|
$42.23
+17.1%
|
| May 28, 2026 |
Argen X SE - ADR
ARGX
|
BUY |
$1,255.00
Est. +50%
|
$838.49 | $953.58 |
Pending
|
$939.68
+12.1%
|
| May 28, 2026 |
Equillium Inc
EQ
|
BUY |
$5.00
Est. +90%
|
$2.63 | $3.54 |
Pending
|
$2.91
+10.6%
|
| May 06, 2026 |
Spyre Therapeutics Inc.
SYRE
|
BUY |
$107.00
Est. +51%
|
$71.01 | $102.06 |
Pending
|
$86.63
+22.0%
|
| Mar 10, 2026 |
Cullinan Therapeutics Inc
CGEM
|
BUY |
$28.00
Est. +85%
|
$15.11 | $19.43 |
Pending
|
$17.63
+16.7%
|
| Mar 09, 2026 |
Dianthus Therapeutics Inc
DNTH
|
BUY |
$120.00
Est. +49%
|
$80.60 | $98.64 |
Pending
|
$94.34
+17.0%
|
| Mar 06, 2026 |
Jade Biosciences, Inc.
JBIO
|
BUY |
$40.00
Est. +184%
|
$14.07 | $27.96 |
Pending
|
$21.51
+52.9%
|
| Mar 05, 2026 |
AnaptysBio Inc
ANAB
|
BUY |
$85.00
Est. +48%
|
$57.36 | $72.27 |
Pending
|
$63.42
+10.6%
|
| Mar 04, 2026 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$332.00
Est. +38%
|
$241.38 | $274.89 |
Pending
|
$274.50
+13.7%
|
| Feb 26, 2026 |
Argen X SE - ADR
ARGX
|
BUY |
$1,227.00
Est. +59%
|
$769.98 | $953.58 |
Pending
|
$939.68
+22.0%
|
| Feb 12, 2026 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$325.00
Est. +49%
|
$218.04 | $274.89 |
Pending
|
$274.50
+25.9%
|
| Jan 05, 2026 |
Crinetics Pharmaceuticals Inc
CRNX
|
BUY |
$75.00
Est. +48%
|
$50.57 | $57.99 |
Pending
|
$42.23
-16.5%
|
| Dec 11, 2025 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$256.00
Est. +27%
|
$201.37 | $274.89 |
Target Met
|
$274.50
+36.3%
|
| Dec 08, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$114.00
Est. +22%
|
$93.76 | $130.05 |
Target Met
|
$113.51
+21.1%
|
| Nov 05, 2025 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$48.00
Est. +98%
|
$24.24 | $34.29 |
Pending
|
$19.40
-20.0%
|
| Sep 18, 2025 |
Argen X SE - ADR
ARGX
|
BUY |
$882.00
Est. +21%
|
$731.77 | $953.58 |
Target Met
|
$939.68
+28.4%
|
| May 05, 2025 |
Jade Biosciences, Inc.
JBIO
|
BUY |
$19.00
Est. +65%
|
$11.50 | $27.96 |
Target Met
|
$21.51
+87.0%
|
| Mar 24, 2025 |
Crinetics Pharmaceuticals Inc
CRNX
|
BUY |
$60.00
Est. +67%
|
$35.94 | $57.99 |
Miss
|
$42.23
+17.5%
|
| Nov 12, 2024 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$41.00
Est. +80%
|
$22.81 | $29.00 |
Miss
|
$19.40
-14.9%
|
| Nov 12, 2024 |
Spyre Therapeutics Inc.
SYRE
|
BUY |
$71.00
Est. +100%
|
$35.52 | $40.26 |
Miss
|
$86.63
+143.9%
|
| Nov 12, 2024 |
RAPT Therapeutics Inc
RAPT
|
BUY |
$2.00
Est. +15%
|
$1.74 | $42.39 |
Target Met
|
$58.01
+3233.6%
|
| Nov 06, 2024 |
Aclaris Therapeutics Inc
ACRS
|
BUY |
$3.00
Est. +32%
|
$2.28 | $5.17 |
Target Met
|
$5.56
+143.9%
|
| Sep 10, 2024 |
Viridian Therapeutics Inc
VRDN
|
BUY |
$40.00
Est. +361%
|
$8.68 | $27.20 |
Miss
|
$19.40
+123.5%
|
| Jul 22, 2024 |
Morphic Holding Inc
MORF
|
BUY |
$57.00
Est. +1%
|
$56.52 | $57.00 |
Bullseye Hit (±1%)
|
$56.99
+0.8%
|
| Jun 24, 2024 |
Argen X SE - ADR
ARGX
|
BUY |
$500.00
Est. +14%
|
$436.79 | $678.21 |
Target Met
|
$939.68
+115.1%
|
| Jun 17, 2024 |
Third Harmonic Bio Inc
THRD
|
BUY |
$23.00
Est. +78%
|
$12.95 | $16.02 |
Miss
|
$5.38
-58.5%
|
| Jun 17, 2024 |
Celldex Therapeutics Inc.
CLDX
|
BUY |
$58.00
Est. +66%
|
$34.91 | $47.00 |
Miss
|
$38.37
+9.9%
|
| May 30, 2024 |
Ascendis Pharma A/S - ADR
ASND
|
BUY |
$200.00
Est. +46%
|
$137.45 | $181.50 |
Miss
|
$274.50
+99.7%
|
| May 13, 2024 |
Apogee Therapeutics Inc.
APGE
|
BUY |
$95.00
Est. +80%
|
$52.71 | $63.50 |
Miss
|
$132.91
+152.2%
|
| May 07, 2024 |
Pliant Therapeutics Inc
PLRX
|
BUY |
$32.00
Est. +130%
|
$13.91 | $16.07 |
Miss
|
$1.17
-91.6%
|
Crinetics Pharmaceuticals Inc
CRNX
Jun 22, 2026
Signal & Target
BUY
$83.00
Start Price
$36.06
Best Price (1Y)
$42.41
Current Price
$42.23
Return
+17.1%
Argen X SE - ADR
ARGX
May 28, 2026
Signal & Target
BUY
$1,255.00
Start Price
$838.49
Best Price (1Y)
$953.58
Current Price
$939.68
Return
+12.1%
Equillium Inc
EQ
May 28, 2026
Signal & Target
BUY
$5.00
Start Price
$2.63
Best Price (1Y)
$3.54
Current Price
$2.91
Return
+10.6%
Spyre Therapeutics Inc.
SYRE
May 06, 2026
Signal & Target
BUY
$107.00
Start Price
$71.01
Best Price (1Y)
$102.06
Current Price
$86.63
Return
+22.0%
Cullinan Therapeutics Inc
CGEM
Mar 10, 2026
Signal & Target
BUY
$28.00
Start Price
$15.11
Best Price (1Y)
$19.43
Current Price
$17.63
Return
+16.7%
Dianthus Therapeutics Inc
DNTH
Mar 09, 2026
Signal & Target
BUY
$120.00
Start Price
$80.60
Best Price (1Y)
$98.64
Current Price
$94.34
Return
+17.0%
Jade Biosciences, Inc.
JBIO
Mar 06, 2026
Signal & Target
BUY
$40.00
Start Price
$14.07
Best Price (1Y)
$27.96
Current Price
$21.51
Return
+52.9%
AnaptysBio Inc
ANAB
Mar 05, 2026
Signal & Target
BUY
$85.00
Start Price
$57.36
Best Price (1Y)
$72.27
Current Price
$63.42
Return
+10.6%
Ascendis Pharma A/S - ADR
ASND
Mar 04, 2026
Signal & Target
BUY
$332.00
Start Price
$241.38
Best Price (1Y)
$274.89
Current Price
$274.50
Return
+13.7%
Argen X SE - ADR
ARGX
Feb 26, 2026
Signal & Target
BUY
$1,227.00
Start Price
$769.98
Best Price (1Y)
$953.58
Current Price
$939.68
Return
+22.0%
Ascendis Pharma A/S - ADR
ASND
Feb 12, 2026
Signal & Target
BUY
$325.00
Start Price
$218.04
Best Price (1Y)
$274.89
Current Price
$274.50
Return
+25.9%
Crinetics Pharmaceuticals Inc
CRNX
Jan 05, 2026
Signal & Target
BUY
$75.00
Start Price
$50.57
Best Price (1Y)
$57.99
Current Price
$42.23
Return
-16.5%
Ascendis Pharma A/S - ADR
ASND
Dec 11, 2025
Signal & Target
BUY
$256.00
Start Price
$201.37
Best Price (1Y)
$274.89
Current Price
$274.50
Return
+36.3%
Kymera Therapeutics Inc
KYMR
Dec 08, 2025
Signal & Target
BUY
$114.00
Start Price
$93.76
Best Price (1Y)
$130.05
Current Price
$113.51
Return
+21.1%
Viridian Therapeutics Inc
VRDN
Nov 05, 2025
Signal & Target
BUY
$48.00
Start Price
$24.24
Best Price (1Y)
$34.29
Current Price
$19.40
Return
-20.0%
Argen X SE - ADR
ARGX
Sep 18, 2025
Signal & Target
BUY
$882.00
Start Price
$731.77
Best Price (1Y)
$953.58
Current Price
$939.68
Return
+28.4%
Jade Biosciences, Inc.
JBIO
May 05, 2025
Signal & Target
BUY
$19.00
Start Price
$11.50
Best Price (1Y)
$27.96
Current Price
$21.51
Return
+87.0%
Crinetics Pharmaceuticals Inc
CRNX
Mar 24, 2025
Signal & Target
BUY
$60.00
Start Price
$35.94
Best Price (1Y)
$57.99
Current Price
$42.23
Return
+17.5%
Viridian Therapeutics Inc
VRDN
Nov 12, 2024
Signal & Target
BUY
$41.00
Start Price
$22.81
Best Price (1Y)
$29.00
Current Price
$19.40
Return
-14.9%
Spyre Therapeutics Inc.
SYRE
Nov 12, 2024
Signal & Target
BUY
$71.00
Start Price
$35.52
Best Price (1Y)
$40.26
Current Price
$86.63
Return
+143.9%
RAPT Therapeutics Inc
RAPT
Nov 12, 2024
Signal & Target
BUY
$2.00
Start Price
$1.74
Best Price (1Y)
$42.39
Current Price
$58.01
Return
+3233.6%
Aclaris Therapeutics Inc
ACRS
Nov 06, 2024
Signal & Target
BUY
$3.00
Start Price
$2.28
Best Price (1Y)
$5.17
Current Price
$5.56
Return
+143.9%
Viridian Therapeutics Inc
VRDN
Sep 10, 2024
Signal & Target
BUY
$40.00
Start Price
$8.68
Best Price (1Y)
$27.20
Current Price
$19.40
Return
+123.5%
Morphic Holding Inc
MORF
Jul 22, 2024
Signal & Target
BUY
$57.00
Start Price
$56.52
Best Price (1Y)
$57.00
Current Price
$56.99
Return
+0.8%
Argen X SE - ADR
ARGX
Jun 24, 2024
Signal & Target
BUY
$500.00
Start Price
$436.79
Best Price (1Y)
$678.21
Current Price
$939.68
Return
+115.1%
Third Harmonic Bio Inc
THRD
Jun 17, 2024
Signal & Target
BUY
$23.00
Start Price
$12.95
Best Price (1Y)
$16.02
Current Price
$5.38
Return
-58.5%
Celldex Therapeutics Inc.
CLDX
Jun 17, 2024
Signal & Target
BUY
$58.00
Start Price
$34.91
Best Price (1Y)
$47.00
Current Price
$38.37
Return
+9.9%
Ascendis Pharma A/S - ADR
ASND
May 30, 2024
Signal & Target
BUY
$200.00
Start Price
$137.45
Best Price (1Y)
$181.50
Current Price
$274.50
Return
+99.7%
Apogee Therapeutics Inc.
APGE
May 13, 2024
Signal & Target
BUY
$95.00
Start Price
$52.71
Best Price (1Y)
$63.50
Current Price
$132.91
Return
+152.2%
Pliant Therapeutics Inc
PLRX
May 07, 2024
Signal & Target
BUY
$32.00
Start Price
$13.91
Best Price (1Y)
$16.07
Current Price
$1.17
Return
-91.6%